Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer

Posted on Posted in Aggregated No Comments Tagged with

CNBC | Biotech giant Regeneron said it aims to have doses of a potential drug for COVID-19 ready to start human clinical trials by early summer.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.